Skip to content
NJ News HubNewsHub

Business

BeOne Medicines plans $300M Hopewell expansion

Source: NJBiz · Jul 23, 2026, 8:40 AM

AI-assisted briefing from the publisher’s public headline and excerpt — not original reporting. How we write briefings

BeOne Medicines plans $300M Hopewell expansion news image

BeOne Medicines announced a $300 million investment in a new pharmaceutical facility in Hopewell, New Jersey, marking a significant expansion for the company.

The project is expected to create approximately 120 jobs in the region. As part of the development, the New Jersey Economic Development Authority (NJEDA) is providing a $33.9 million tax credit to support the initiative, demonstrating state commitment to attracting and retaining pharmaceutical manufacturing operations.

Key points

  • BeOne Medicines is investing $300 million in a new Hopewell pharmaceutical facility
  • The expansion project will create approximately 120 new jobs
  • NJEDA is providing a $33.9 million tax credit to support the facility
  • The investment represents significant economic development for the Hopewell area

FAQ

Where is BeOne Medicines building its new facility?
BeOne Medicines is constructing its new pharmaceutical facility in Hopewell, New Jersey.
How many jobs will the expansion create?
The $300 million expansion project is expected to create approximately 120 new jobs.
What financial incentive is the state providing?
The New Jersey Economic Development Authority (NJEDA) is providing a $33.9 million tax credit to support the facility development.

Briefing prepared for NJ News Hub. Verify details on the original story. See our editorial policy.

Related